That would be beyond incredible result. Not sure how it gets there at all R&D is super slow and really just the same product in different shapes and sizes. I’d be happy with a buyout at $6-7 seems fair to me and a bigger company still has plenty to work with.
Only way that changes is if they can do that diabetes slow release thing. Many years away…
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
-0.013(1.03%) |
Mkt cap ! $837.6M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.19 | $1.619M | 1.350M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 49632 | $1.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.21 | 29400 | 33 |
View Market Depth
| Last trade - 15.41pm 18/06/2025 (20 minute delay) ? |
| PNV (ASX) Chart |